Rights and permissions
About this article
Cite this article
Switch to ezetimibe/simvastatin proves worthwhile in the UK. Pharmacoecon. Outcomes News 609, 9 (2010). https://doi.org/10.2165/00151234-201006090-00020
Published:
Issue Date:
DOI: https://doi.org/10.2165/00151234-201006090-00020